SpringerLink
Log in

Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  • Review Article
  • Published:
Indian Journal of Surgical Oncology Aims and scope Submit manuscript

Abstract

Goblet cell carcinoma (GCC) encompasses a separate entity in appendiceal neoplasms with mixed glandular and neuro-endocrine pathological features. GCC mostly presents as an acute appendicitis duo to luminal obstruction or as an incidental finding on the surgical appendectomy specimen. In case of tumour perforation or presence of other risk factors, guidelines suggest additional treatment with a completing right hemicolectomy or cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). We report the case of a 77-year-old male with symptoms of appendicitis for which an appendectomy was performed. The appendix was ruptured during the procedure. There was an incidental finding of GCC on the pathological specimen. Because of possible tumour soiling, the patient received a prophylactic CRS-HIPEC. A literature review was performed to investigate the potential role for CRS-HIPEC as a curative treatment in patients with GCC. GCC of the appendix is an aggressive type of tumour with a high risk of peritoneal and systemic dissemination. CRS and HIPEC is a treatment option: both in a prophylactic setting and in patients with established peritoneal metastases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Roy P (2010) Goblet cell carcinoid tumors of the appendix: an overview. World J Gastrointest Oncol 2:251. https://doi.org/10.4251/wjgo.v2.i6.251

    Article  PubMed  PubMed Central  Google Scholar 

  2. Huang D, Ren F, Ni S et al (2019) Amphicrine carcinoma of the stomach and intestine: a clinicopathologic and pan-cancer transcriptome analysis of a distinct entity. Cancer Cell Int 19:1–13. https://doi.org/10.1186/s12935-019-1031-7

    Article  CAS  Google Scholar 

  3. McCusker ME, Coté TR, Clegg LX, Sobin LH (2002) Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973–1998. Cancer 94:3307–3312. https://doi.org/10.1002/cncr.10589

    Article  PubMed  Google Scholar 

  4. Gui X, Qin L, Gao ZH et al (2011) Goblet cell carcinoids at extraappendiceal locations of gastrointestinal tract: an underrecognized diagnostic pitfall. J Surg Oncol 103:790–795. https://doi.org/10.1002/jso.21863

    Article  PubMed  Google Scholar 

  5. Shibuya H, Hijioka S, Mizuno N et al (2018) A rare case of ampullary goblet cell carcinoid. Intern Med 57:2489–2496. https://doi.org/10.2169/internalmedicine.0516-17

    Article  PubMed  PubMed Central  Google Scholar 

  6. Gallegos NC, Milroy C, Linehan IP, Boulos PB (1992) Crypt cell carcinoma of the appendix. Eur J Surg Oncol 18:386–387

    CAS  PubMed  Google Scholar 

  7. Pahlavan PS, Kanthan R (2005). Goblet cell carcinoid of the appendix. https://doi.org/10.1186/1477-7819-3

    Article  Google Scholar 

  8. Lee KS, Tang LH, Shia J et al (2013) Goblet cell carcinoid neoplasm of the appendix: clinical and CT features. Eur J Radiol 82:85–89. https://doi.org/10.1016/j.ejrad.2012.05.038

    Article  CAS  PubMed  Google Scholar 

  9. Pickhardt PJ, Levy AD, Rohrmann CA, Kende AI (2003) Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation. Radiographics 23:645–662. https://doi.org/10.1148/RG.233025134

    Article  PubMed  Google Scholar 

  10. Zhang K, Meyerson C, Kassardjian A et al (2019) Goblet cell carcinoid/carcinoma: an update. Adv Anat Pathol 26:75–83. https://doi.org/10.1097/PAP.0000000000000222

    Article  PubMed  Google Scholar 

  11. Mo S, Zhou Z, Ying Z et al (2019) Epidemiology of and prognostic factors for appendiceal carcinomas: a retrospective, population-based study. Int J Colorectal Dis 34:1915–1924. https://doi.org/10.1007/s00384-019-03387-y

    Article  PubMed  Google Scholar 

  12. Tang LH, Shia J, Soslow RA, et al (2008) Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix

  13. Turaga KK, Pappas SG, Gamblin TC (2012) Importance of histologic subtype in the staging of appendiceal tumors. Ann Surg Oncol 19:1379–1385. https://doi.org/10.1245/S10434-012-2238-1

    Article  PubMed  Google Scholar 

  14. Reid MD, Basturk O, Shaib WL et al (2016) Adenocarcinoma ex-goblet cell carcinoid (appendiceal-type crypt cell adenocarcinoma) is a morphologically distinct entity with highly aggressive behavior and frequent association with peritoneal/intra-abdominal dissemination: an analysis of 77 cases. Mod Pathol 29:1243–1253. https://doi.org/10.1038/MODPATHOL.2016.105

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pham TH, Wolff B, Abraham SC, Drelichman E (2006) Surgical and chemotherapy treatment outcomes of goblet cell carcinoid: a tertiary cancer center experience. Ann Surg Oncol 13:370–376. https://doi.org/10.1245/ASO.2006.02.016

    Article  PubMed  Google Scholar 

  16. Govaerts K, Lurvink RJ, de Hingh IHJT et al (2021) Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 47:11–35. https://doi.org/10.1016/J.EJSO.2020.02.012

    Article  CAS  PubMed  Google Scholar 

  17. Pape UF, Perren A, Niederle B et al (2012) ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology 95:135–156. https://doi.org/10.1159/000335629

    Article  CAS  PubMed  Google Scholar 

  18. Lee WS, Choi ST, Lee JN et al (2011) A retrospective clinicopathological analysis of appendiceal tumors from 3,744 appendectomies: a single-institution study. Int J Colorectal Dis 26:617–621. https://doi.org/10.1007/S00384-010-1124-1

    Article  PubMed  Google Scholar 

  19. Murphy EMA, Farquharson SM, Moran BJ (2006) Management of an unexpected appendiceal neoplasm. Br J Surg 93:783–792. https://doi.org/10.1002/BJS.5385

    Article  CAS  PubMed  Google Scholar 

  20. Boudreaux JP, Klimstra DS, Hassan MM et al (2010) The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 39:753–766. https://doi.org/10.1097/MPA.0b013e3181ebb2a5

    Article  PubMed  Google Scholar 

  21. Madsen AH, Ladekarl M, Villadsen GE et al (2018) Effects of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of goblet cell carcinoma: a prospective cohort study. Ann Surg Oncol 25:422–430. https://doi.org/10.1245/S10434-017-6272-X

    Article  PubMed  Google Scholar 

  22. McConnell YJ, Mack LA, Gui X et al (2014) Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: an emerging treatment option for advanced goblet cell tumors of the appendix. Ann Surg Oncol 21:1975–1982. https://doi.org/10.1245/S10434-013-3469-5

    Article  PubMed  Google Scholar 

  23. Mahteme H, Sugarbaker PH (2004) Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin. Br J Surg 91:1168–1173. https://doi.org/10.1002/BJS.4609

    Article  CAS  PubMed  Google Scholar 

  24. Hsin-Hsien Y, Yonemura Y, Mao-Chih H et al (2017) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for appendiceal goblet cell carcinomas with peritoneal carcinomatosis: results from a single specialized center. Cancer Manag Res 9:513–523. https://doi.org/10.2147/CMAR.S147227

    Article  Google Scholar 

  25. Shyu S, Choudry H, Hall L et al (2020) Clinicopathological analysis of appendiceal goblet cell adenocarcinoma with peritoneal metastasis: World Health Organization grade predicts survival following cytoreductive surgery with intraperitoneal chemotherapy. Histopathology 77:798–809. https://doi.org/10.1111/his.14189

    Article  PubMed  Google Scholar 

  26. Radomski M, Pai RK, Shuai Y et al (2016) Curative surgical resection as a component of multimodality therapy for peritoneal metastases from goblet cell carcinoids. Ann Surg Oncol 23:4338–4343. https://doi.org/10.1245/S10434-016-5412-Z

    Article  PubMed  Google Scholar 

  27. Taggart MW, Abraham SC, Overman MJ et al (2015) Goblet cell carcinoid tumor, mixed goblet cell carcinoid-adenocarcinoma, and adenocarcinoma of the appendix: comparison of clinicopathologic features and prognosis. Arch Pathol Lab Med 139:782–790. https://doi.org/10.5858/ARPA.2013-0047-OA

    Article  PubMed  Google Scholar 

  28. Yan TD, Brun EA, Sugarbaker PH discordant histology of primary appendiceal adenocarcinoid neoplasms with peritoneal dissemination. https://doi.org/10.1245/s10434-007-9754-4

  29. Shenoy S (2016) Goblet cell carcinoids of the appendix: tumor biology, mutations and management strategies. World J Gastrointest Surg 8:660–669. https://doi.org/10.4240/wjgs.v8.i10.660

    Article  PubMed  PubMed Central  Google Scholar 

  30. Madani A, van der Bilt JDW, Consten ECJ, et al Perforation in appendiceal well-differentiated carcinoid and goblet cell tumors: impact on prognosis? A systematic review. https://doi.org/10.1245/s10434-014-4023-9

  31. Nagtegaal ID, Odze RD, Klimstra D et al (2020) The 2019 WHO classification of tumours of the digestive system. Histopathology 76:182–188. https://doi.org/10.1111/HIS.13975

    Article  PubMed  Google Scholar 

  32. van der Speeten K, Lemoine L, Sugarbaker P (2017) Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice. Pleura Peritoneum 2:63–72. https://doi.org/10.1515/PP-2017-0003/ASSET/GRAPHIC/PP-2017-0003_FIGURE1.JPG

    Article  PubMed  PubMed Central  Google Scholar 

  33. van der Speeten K, Stuart OA, Mahteme H, Sugarbaker PH (2010) Pharmacology of perioperative 5-fluorouracil. J Surg Oncol 102:730–735. https://doi.org/10.1002/jso.21702

    Article  CAS  PubMed  Google Scholar 

  34. Elias D, Lefevre JH, Chevalier J et al (2008) Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 27:681–685. https://doi.org/10.1200/JCO.2008.19.7160

    Article  PubMed  Google Scholar 

  35. Muggia FM (2009) Heidelberger symposium on the 50th anniversary of fluoropyrimidines. https://doi.org/10.1158/1535-7163.MCT-08-0732

  36. Jiang Y, Long H, Li T et al (2012) Schistosomiasis may contribute to goblet cell carcinoid of the appendix. J Parasitol 98:565–568. https://doi.org/10.1645/JP-GE-2865.1

    Article  PubMed  Google Scholar 

  37. Bell PD, Pai RK (2022) Goblet cell adenocarcinoma of the appendix: an update and practical approach to diagnosis and grading. Hum Pathol. https://doi.org/10.1016/J.HUMPATH.2022.06.002

    Article  PubMed  Google Scholar 

  38. Arai H, Baca Y, Battaglin F et al (2020) Molecular characterization of appendiceal goblet cell carcinoid. Mol Cancer Ther 19:2634–2640. https://doi.org/10.1158/1535-7163.MCT-20-0318

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Johncilla M, Stachler M, Misdraji J et al (2018) Mutational landscape of goblet cell carcinoids and adenocarcinoma ex goblet cell carcinoids of the appendix is distinct from typical carcinoids and colorectal adenocarcinomas. Mod Pathol 31:989–996. https://doi.org/10.1038/S41379-018-0003-0

    Article  CAS  PubMed  Google Scholar 

  40. Jesinghaus M, Konukiewitz B, Foersch S et al (2018) Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix. Mod Pathol 31:829–839. https://doi.org/10.1038/MODPATHOL.2017.184

    Article  CAS  PubMed  Google Scholar 

  41. Lee LH, McConnell YJ, Tsang E et al (2015) Simplified 2-tier histologic grading system accurately predicts outcomes in goblet cell carcinoid of the appendix. Hum Pathol 46:1881–1889. https://doi.org/10.1016/J.HUMPATH.2015.08.005

    Article  PubMed  Google Scholar 

  42. Rossi RE, Luong TV, Caplin ME et al (2015) Goblet cell appendiceal tumors–management dilemmas and long-term outcomes. Surg Oncol 24:47–53. https://doi.org/10.1016/J.SURONC.2015.01.001

    Article  PubMed  Google Scholar 

  43. Holt N, Grønbæk H (2013) Goblet cell carcinoids of the appendix. ScientificWorldJournal 2013:. https://doi.org/10.1155/2013/543696

  44. Dromain C, de Baere T, Lumbroso J et al (2005) Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J Clin Oncol 23:70–78. https://doi.org/10.1200/JCO.2005.01.013

    Article  PubMed  Google Scholar 

  45. Maggard MA, O’Connell JB, Ko CY (2004) Updated population-based review of carcinoid tumors. Ann Surg 240:117–122. https://doi.org/10.1097/01.SLA.0000129342.67174.67

    Article  PubMed  PubMed Central  Google Scholar 

  46. Burke AP, Sobin LH, Federspiel BH et al (1990) Goblet cell carcinoids and related tumors of the vermiform appendix. Am J Clin Pathol 94:27–35. https://doi.org/10.1093/AJCP/94.1.27

    Article  CAS  PubMed  Google Scholar 

  47. Patel GS, Karapetis CS (2013) Personalized treatment for advanced colorectal cancer: KRAS and beyond. Cancer Manag Res 5:387–400. https://doi.org/10.2147/CMAR.S35025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Liu DSH, Read M, Cullinane C et al (2015) APR-246 potently inhibits tumour growth and overcomes chemoresistance in preclinical models of oesophageal adenocarcinoma. Gut 64:1506–1516. https://doi.org/10.1136/GUTJNL-2015-309770

    Article  CAS  PubMed  Google Scholar 

  49. Lehmann S, Bykov VJN, Ali D et al (2012) Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. J Clin Oncol 30:3633–3639. https://doi.org/10.1200/JCO.2011.40.7783

    Article  CAS  PubMed  Google Scholar 

  50. Wang HL, Dhall D (2009) Goblet or signet ring cells: that is the question. Adv Anat Pathol 16:247–254. https://doi.org/10.1097/PAP.0B013E3181A9D49A

    Article  PubMed  Google Scholar 

  51. Yozu M, Johncilla ME, Srivastava A et al (2018) Histologic and outcome study supports reclassifying appendiceal goblet cell carcinoids as goblet cell adenocarcinomas, and grading and staging similarly to colonic adenocarcinomas. Am J Surg Pathol 42:898–910. https://doi.org/10.1097/PAS.0000000000001056

    Article  PubMed  Google Scholar 

  52. Varisco B, Mcalvin B, Dias J, Franga D (2022) Adenocarcinoid of the appendix: is right hemicolectomy necessary? A meta-analysis of retrospective chart reviews. https://doi-org.kuleuven.e-bronnen.be/101177/000313480407000706 70:593–599. https://doi.org/10.1177/000313480407000706

  53. Bucher P, Gervaz P, Ris F et al (2005) Surgical treatment of appendiceal adenocarcinoid (goblet cell carcinoid). World J Surg 29:1436–1439. https://doi.org/10.1007/S00268-005-7958-Y

    Article  PubMed  Google Scholar 

  54. Schuitevoerder D, Plana A, Izquierdo FJ et al (2020) The Chicago consensus on peritoneal surface malignancies: management of appendiceal neoplasms. Ann Surg Oncol 27:1753–1760. https://doi.org/10.1245/S10434-020-08316-W

    Article  Google Scholar 

  55. Fields AC, Lu P, Enzinger A et al (2019) Treatment patterns and outcomes in goblet cell carcinoid tumors of the appendix. J Surg Oncol 120:1096. https://doi.org/10.1002/jso.25723

    Article  PubMed  PubMed Central  Google Scholar 

  56. Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374. https://doi.org/10.1007/978-1-4613-1247-5_23

    Article  CAS  PubMed  Google Scholar 

  57. Randle RW, Griffith KF, Fino NF et al (2015) Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Surg Res 196:229–234. https://doi.org/10.1016/J.JSS.2015.03.051

    Article  PubMed  PubMed Central  Google Scholar 

  58. Lamarca A, Nonaka D, Lopez Escola C et al (2016) Appendiceal goblet cell carcinoids: management considerations from a reference peritoneal tumour service centre and ENETS centre of excellence. Neuroendocrinology 103:500–517. https://doi.org/10.1159/000440725

    Article  CAS  PubMed  Google Scholar 

  59. Klaver G, Wisselink CEL, Punt DD et al (2019) Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC) COLOPEC Citation for published version (APA): COLOPEC Collaborators Grp Articles Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial. 761. https://doi.org/10.1016/S2468-1253(19)30239-0

  60. Arjona-Sanchez A, Cano-Osuna MT, Gutierrez A et al (2022) 314O Adjuvant hyperthermic intraperitoneal chemotherapy in locally advanced colon cancer (HIPECT4): a randomized phase III study. Ann Oncol 33:S680. https://doi.org/10.1016/j.annonc.2022.07.452

    Article  Google Scholar 

  61. Dindo D, Demartines N, Clavien P-A, Clavien P-A (2004) Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of Surgery • 240. https://doi.org/10.1097/01.sla.0000133083.54934.ae

  62. Piso P, Nedelcut SD, Rau B et al (2019) Morbidity and mortality following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: data from the DGAV StuDoQ registry with 2149 consecutive patients. Ann Surg Oncol 26:148–154. https://doi.org/10.1245/S10434-018-6992-6

    Article  PubMed  Google Scholar 

  63. Mizumoto A, Canbay E, Hirano M, et al (2012) Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterol Res Pract 2012. https://doi.org/10.1155/2012/836425

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Ziekenhuis Oost-Limburg, Schiepse Bos 6, 3600, Genk, Belgium

    M. Gaillard & K. Van der Speeten

  2. Department of Pathology, Ziekenhuis Oost-Limburg, Schiepse Bos 6, 3600, Genk, Belgium

    P. Van Eyken

  3. Department of Radiology, Ziekenhuis Oost-Limburg, Schiepse Bos 6, 3600, Genk, Belgium

    G. Verswijvel

  4. Department of Medicine and Life Sciences, Hasselt University, Hasselt, Belgium

    K. Van der Speeten

Authors
  1. M. Gaillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Van Eyken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Verswijvel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Van der Speeten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Van der Speeten.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaillard, M., Van Eyken, P., Verswijvel, G. et al. Appendiceal Goblet Cell Carcinoma: Role of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Indian J Surg Oncol 14 (Suppl 1), 240–249 (2023). https://doi.org/10.1007/s13193-023-01748-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13193-023-01748-2

Keywords

Search

Navigation